Cardiac hypertrophy in athletes.
نویسندگان
چکیده
منابع مشابه
Cardiac hypertrophy in athletes.
The outstanding physical ability of top athletes and the frequency with which world records are broken continue to fascinate layman and physiologist alike. It is generally assumed that such great achievements are the outcome of ever more rigorous and prolonged training programmes, which cause, among other things, adaptation of the heart in various ways. The most prominent of these is left ventr...
متن کاملCardiopulmonary receptor reflexes in normotensive athletes with cardiac hypertrophy.
Cardiopulmonary receptor control of the circulation is impaired in a variety of diseases having cardiac hypertrophy as a common feature. Whether this also occurs in the so-called "physiological" cardiac hypertrophy of the athlete, however, is unknown. We studied nine sedentary healthy subjects and 19 age-matched professional runners or hammer throwers who had trained at least 2 hours per day, 5...
متن کاملLeft ventricular hypertrophy in athletes.
Participation in regular intensive exercise is associated with a modest increase in left ventricular wall thickness (LVWT) and cavity size. The magnitude of these physiological changes is predominantly determined by a variety of demographic factors which include age, gender, size, ethnicity, and sporting discipline. A small minority of male athletes participating in sporting disciplines involvi...
متن کاملDo big athletes have big hearts? Impact of extreme anthropometry upon cardiac hypertrophy in professional male athletes
AIM Differentiating physiological cardiac hypertrophy from pathology is challenging when the athlete presents with extreme anthropometry. While upper normal limits exist for maximal left ventricular (LV) wall thickness (14 mm) and LV internal diameter in diastole (LVIDd, 65 mm), it is unknown if these limits are applicable to athletes with a body surface area (BSA) >2.3 m(2). PURPOSE To inves...
متن کاملCarvacrol Ameliorates Pathological Cardiac Hypertrophy in Both In-vivo and In-vitro Models
Hypertension-induced left ventricular hypertrophy is the most important risk factor for heart failure. This study aimed at investigating the effects of monoterpenoid phenol, carvacrol, on myocardial hypertrophy using both in-vivo and in-vitro models. Male Wistar rats were divided into the control (Ctl), un-treated hypertrophy (H), and carvacrol-treated hypertrophy gro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Heart
سال: 1984
ISSN: 1355-6037
DOI: 10.1136/hrt.52.2.121